Shopping Cart
- Remove All
- Your shopping cart is currently empty
Trabikibart (CSL311), a βc-specific, fully human monoclonal antibody, specifically binds to the cytokine-binding epitope of the human βc receptor with picomolar affinity. It potently inhibits the collective impact of IL-3, GM-CSF, and IL-5 on eosinophil survival, underscoring its potential in chronic inflammatory diseases research [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $195 | 8-10 weeks | |
5 mg | $483 | 8-10 weeks | |
10 mg | $692 | 8-10 weeks | |
25 mg | $1,080 | 8-10 weeks | |
50 mg | $1,490 | 8-10 weeks |
Description | Trabikibart (CSL311), a βc-specific, fully human monoclonal antibody, specifically binds to the cytokine-binding epitope of the human βc receptor with picomolar affinity. It potently inhibits the collective impact of IL-3, GM-CSF, and IL-5 on eosinophil survival, underscoring its potential in chronic inflammatory diseases research [1]. |
Alias | CSL311 |
Cas No. | 2643974-98-3 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.